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The thymus plays a crucial role in the generation of T-cells, and so our laboratory has been interested in
the study of the intrathymic events that occur during infection diseases and may cause disruption in its
functions. Previously, we showed that thymus from experimentally Plasmodium berghei-infected mice
present histological alterations with high levels of apoptosis, changes in cell migration-related molecules,
and premature egress of immature thymocytes to periphery. In addition, parasites were found inside the
thymus. In this work we investigated alterations in the expression pattern and activity of matrix metallo-
proteinases MMP-2 and -9, and their tissue inhibitors, TIMP-1 and TIMP-2. Our results show enhanced
expression and widespread distribution of these molecules in thymus from infected animals. Also, the
presence of active MMP-2 was detected. These data are suggestive of MMPs and TIMPs importance in
the earlier observed changes in the extracellular matrix during thymic alterations after plasmodium
infection.
 2012 Elsevier Inc. Open access under the Elsevier OA license.1. Introduction
The thymus, a central lymphoid organ, plays an important role
in the generation of the T cell repertoire. The thymic microenviron-
ment (composed by lymphoepithelial stroma and by the secretory
products of the thymic epithelium) provides an appropriated
milieu for the development and differentiation of immature
T-lymphoid precursors into functionally mature T cells that will
be able to carry out immune functions in the periphery. The suc-
cessful development of mature T cells depends on the constant
and organized migration of the immature T cell (or thymocytes
while in the thymus) through different thymic niches. Such migra-
tion is essential for thymocyte receive signals (like chemokines,
extracellular matrix (ECM) proteins, and their respective receptors)
that lead these cells to proliferation, differentiation and generation
of diversity [1–4]. So, it is plausible to suppose that alterations in
the thymic microenvironment can inﬂuence the process of T cell
maturation.
Since the thymus can be a target organ for several pathogens,
like fungus, virus and parasites [5], our laboratory has been inter-sevier OA license. 
e Biologia Estrutural e Func-
sitária Zeferino, Vaz s/n, CEP:
35216276.
).ested in the study of the intrathymic events that may cause a dis-
ruption of normal thymic functions [6,7]. Previously, we have
reported that the thymus gland is also a target organ during the
infection with Plasmodium berghei, the etiological agent of Malaria
[8]. In addition to detecting the intrathymic presence of parasites
in experimentally infected mice, we observed severe thymic alter-
ations characterized by histological changes, high levels of apopto-
sis, altered expression of cytokines and ECM proteins that,
conjunctively, promotes an increase of thymocyte migratory activ-
ity with consequent premature egress of immature cells to the
peripheral lymphoid organs [9,10].
ECM composition and turnover are regulated by a variety of en-
zymes among which matrix metalloproteinases (MMPs) seem to
be the most important [11]. MMPs are classiﬁed into different fam-
ilies [12–17] one of which is the family of gelatinases that includes
MMP-2 (Gelatinase A) and MMP-9 (Gelatinase B). Literature has
shown that the expression of MMP-9, for example, is important
for the remodeling of the ECM and the migration of cells [18]. As
both of these functions are essential components of T-cell matura-
tion it would be reasonable to suppose that MMPs have a crucial
role during the intrathymic thymocyte migration.
Although information regarding MMPs, as well as their natural
tissue inhibitors (TIMPs), during the events of thymocyte migra-
tion is quite limited, it is plausible to suppose that ECM in thymus
are also controlled by these proteins. Indeed, evidences have
showed that thymic microenviromental cells produce MMP-9,
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potential regulatory function of MMPs on intrathymic, ECM-
mediated interactions has recently been suggested [11,20].
However, roles of these MMPs and TIMPS on thymic atrophy
observed during infection have not been characterized clearly.
Considering that MMPs must also play a role in the intrathymic
ECM control, in this study we investigated changes in the expres-
sion pattern and activity of matrix metalloproteinases MMP-2
and MMP-9, as well as in their natural tissue inhibitors, TIMP-1
and TIMP-2, with the aim to better comprehend the events in-
volved in the thymic alterations observed during plasmodium
infection.2. Material and methods
2.1. Animals
Speciﬁc pathogen free BALB/c male mice (aged 6–8 weeks),
obtained from Centro Multi-Institucional de Bioterismo (CEMIB)
were used. They were kept in groups of ﬁve in transparent acrylic
plastic isolators under aseptic conditions on a 12 h light/dark cycle
throughout the study. Sterile water and food were provided ad
libitum. All procedures were carried out in accordance with the
guidelines proposed by the Brazilian Council on Animal Care
(COBEA) and approved by the animal care and use committee of
the State University of Campinas (protocol no. 1789-1).2.2. Infection of mice
Groups of ﬁve to ten animals were intraperitoneally infected
with 5  106 Plasmodium berghei NK65 parasitized red blood cells
obtained from a source mouse or with saline (control groups).
Parasitemia and mortality were assessed every other day by the
examination of Giemsa-stained thin blood smears. At days 5, 10
and 14 following infection, mice were sacriﬁced and their thy-
muses were collected for analyses.2.3. Thymic index
The gross weight of each mouse was recorded on 5, 10 and
14 days of infection and compared with pre-infection weight. The
animals were sacriﬁced with xylazine/ketamine (100 mg/kg hypo-
chlorite 5 mg/kg of ketamine hydrochloride and xylazine) inocula-
tion. After that, the thymus glands were aseptically removed and
weighed. The thymic index was calculated as: (organ weight (g)/
body weight (g))  100.2.4. RT-qPCR/real time quantitative PCR
Total RNA was extracted from thymus using Illustra RNAspin
Mini (GE Healthcare, Amersham, UK) in accordance with the man-
ufacturer’s instructions. RNA yield was evaluated spectrophoto-
metrically (A260/A280) and RNA aliquots were stored at 80 C
until use. Generation of cDNA was performed with High Capacity
cDNA Reverse Transcription Kit (Applied Biosystems, Foster City,
CA, USA) according to the manufacturer’s instructions. Polymerase
chain reaction was performed in an ABI Prism 7300 equipment and
the reactionswere carried out in 20 lL volume composed byMaster
Mix (Applied Biosystems, Foster City, CA, USA), DEPC water and
speciﬁc inventoried assays of primers with TaqMan probes, as fol-
low: 18s: HS Hs99999901_s1, MMP-2: Mm01253624_m1, MMP-
9: Mm00600164_g1, TIMP-1: Mm01341361_m1 and TIMP-2
Mm00441825_m1 obtained from Applied Biosystems. Expression
levels of genes in control and infected mice were represented as arelative copy numbers by using the delta threshold cycle method
(2DDCt) [21].
2.5. Gelatin zymography
Thymus fragments (n = 5 in control group and n = 10 in infected
mice) were triturated in a solution of 50 mM Tris–HCl, pH 7.4,
0.2 M NaCl, 0.1% Triton 100, 10 mM CaCl2 and 1% protease inhibi-
tor cocktail (Sigma) for protein extraction. Total protein was quan-
tiﬁed according to the method of Bradford [22] using bovine serum
albumin (Sigma) as a standard. The zymography assays were per-
formed on 7.5% polyacrylamide electrophoresis gels containing
0.1% gelatin and using 20 lg of protein per sample. After electro-
phoresis, the gels were washed with 2.5% Triton 100 at room tem-
perature and incubated overnight in a solution of 50 mM Tris–HCl,
pH 7.4, 0.1 M NaCl and 0.03% sodium azide at 37 C. After that the
gels were stained with Coomassie Brilliant Blue. The protein bands
corresponding to gelatinolytic activity were observed after wash-
ing the gels with a solution containing 30% methanol and 10% ace-
tic acid. The gel was evaluated by band densitometry using the
SCION IMAGE program. Each sample was analyzed individually
and the experiments were repeated three times.
2.6. Immunohistochemical analysis
In situ expression of Cytokeratin-5, Cytokeratin-8, MMP-2,
MMP-9, TIMP-1, and TIMP-2 in thymus from infected and control
animals were performed following protocol for immunohistochem-
istry stain. At sacriﬁce, thymuses were obtained and ﬁxed in para-
phormaldehyde in 0, 2 M Phosphate Buffer for 24 h. So, they pass
through a dehydratation and paraﬁn bath protocol composed by
incubation of tissue in crescent concentration of ethanol, xilol and
paraﬁn. For last, slices of 5 um were obtained for immunohisto-
chemistry stain procedure. Then, thymus sections were deparafﬁ-
nized with xylene, hydrated in an ethanol gradient and water
before stain reaction. Right after, was performed an incubationwith
3%H2O2 in absolutemethanol (v/v) to block endogenous peroxidase
activity. From here all procedures were done according to Immuno-
CruzTM rabbit ABC Staining System (sc-2018) or ImmunoCruzTM
goat ABC Staining System (sc-2023) datasheet. Brieﬂy, all sections
were incubated with speciﬁc serum to avoid secondary antibody
nonspeciﬁc binding for 1 h at 4 C, and then they were incubated
with speciﬁc primary antibodies to mouse proteins for 16 h at
4 C. Primary antibodies were purchased from Santa Cruz (MMP-
2, MMP-9, TIMP-1 and TIMP-2) or AbCam (CK5 and CK8). After
washing, sections were overlaid for 1 h with a speciﬁc secondary
antibody biotin-conjugated. This was followed by incubation with
AB enzyme reagent to ampliﬁcation of signal reaction. Bound anti-
bodies was detected by reactivity with 3, 3‘-diaminobenzidine plus
H2O2. After tap washing, the slides were counterstained by Harris
Haematoxilin and mounted with Permount. For immunohisto-
chemistry controls primary antibodies were omitted from the
staining procedure and were negative for any reactivity.
2.7. Statistical analysis
Statistical analyses were determined using unpaired t test and
Prism 5.0 software (GraphPad Software Inc., La Jolla, CA, USA). Data
are expressed as mean ± SD, and p values equal or lower than 0.05
were considered to be statistically signiﬁcant.3. Results
Parasitemia and mortality rates in the experimental group
infected with Plasmodium berghei NK65 parasitized erythrocytes
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15 days of infection and 100% mortality at 16 days post-infection
(Fig. 1).
A severe decrease of the thymus relative weight in infected
group was observed when compared to the control group
(Fig. 2A). This atrophy was also accompanied by changes in the
organ histological pattern that shows constriction of the cortical
layer, more diffuse medullar region, and decreased cellularity of
cortex and medulla regions as depicted by immunolabeling for
cytokeratin-8 and cytokeratin-5, respectively (Fig. 2B).
Fig. 3 shows the mRNA expression levels of metalloproteinases
as well as their natural tissue inhibitors during thymic atrophyFig. 1. Parasitemia and mortality rates in mice infected with 5  106 parasitized RBCs. At
Fig. 2. Thymic alterations in Plasmodium berghei-infected mice. (A): a severe decrease of
mean ± standard error (SE) for at least ﬁve animals;⁄p 6 0.01; ⁄⁄⁄p 6 0.001. The control ba
the cortical layer, more diffuse medullar region, and intense reduction of cellularity in bot
at 14 days of infection. The ﬁgures are representative of at least three experiments perfinduced by Plasmodium berghei NK65. An increased gene expres-
sion of MMP-2, MMP-9, TIMP-1 and TIMP-2 can be observed in in-
fected animals at 10 days post-infection. At 14 days after infection,
however, the gene expression of these molecules is similar to that
observed in the beginning of infection (at 5 days of infection).
Immunohistochemical localization and expression intensity of
the matrix metalloproteinases MMP-2 and MMP-9 and their tissue
inhibitors, TIMP-1 and TIMP-2, within the thymus during
plasmodium infection was performed.
It can be noted that at 5 days of infection MMP-2 and MMP-9
are more prevalent in the medullar region of the organ, but they
acquired a widespread distribution throughout the thymic tissue15 days of infection, animals presented the peak of parasitemia and 100% were dead.
the thymus relative weight is observed in infected group. Results are expressed as
r is representative since the data were similar at each time point. (B): constriction of
h cortical (cytokeratin-8) and medullar (cytokeratin-5) thymic regions was observed
ormed on different experimental days. Insert: negative control. Bar: 10 lm.
Fig. 3. Relative mRNA expression levels of MMPs and TIMPs during thymic atrophy induced by Plasmodium berghei NK65. At 10 days after infection, an intense increase of
speciﬁc messenger RNA for MMP2 and MMP9, as well as for TIMP1 and TIMP2, was observed in the thymus from infected mice. Results are expressed as mean ± SE for at least
ﬁve animals. (⁄⁄⁄p 6 0.0001). The control bars are representative since the data were similar at each time point.
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intensity of MMP-2 and MMP-9 is markedly increased at 14 days
after infection when compared to the control group (Fig. 4, bottom
panel).Fig. 4. Immunohistochemical localization (upper panel) and expression intensity (bottom
by Plasmodium berghei NK65. Upper panel: Note that MMP-2 and MMP-9 are more preval
throughout the thymic tissue as the disease progresses. Bar: 5 lm. Bottom panel: expr
compared to the control group. (⁄p 6 0.01; p⁄⁄⁄ 6 0.001). The control bars are representaImmunohistochemical results show that in infected groups the
expression of TIMP1 and TIMP2 is mild and restrict to the endothe-
lia at the beginning of infection, but intense and widespread at
14 days of infection (Fig. 5, upper panel). As observed for metallo-panel) of metalloproteinases, MMP-2 and MMP-9, during thymic atrophy induced
ent in the medullar region of the organ, but they acquired a widespread distribution
ession intensity of MMP-2 and MMP-9 was higher at 14 days after infection when
tive since the data were similar at each time.
Fig. 5. Immunohistochemical localization (upper panel) and expression intensity (bottom panel) of natural tissue inhibitors of metalloproteinases, TIMP-1 and TIMP-2,
during thymic atrophy induced by Plasmodium berghei NK65. Upper panel: Note that the expression of TIMP-1 and TIMP-2 is mild and restrict to the endothelia at the
beginning of infection, but intense and widespread at 14 days of infection. Bar: 5 lm. Bottom panel: expression intensity of TIMP-1 and TIMP-2 was higher at 14 days after
infection when compared to the control group. (⁄⁄⁄p 6 0.001). The control bars are representative since the data were similar at each time.
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14 days post-infection (Fig. 5, bottom panel).
Gelatinolytic activities with various molecular masses were de-
tected in the thymus extracts (Fig. 6A). The 62, 68, and 72 kDa
bands correspond, respectively, to the active, intermediate, and
precursor states of MMP-2. The bands for the latent and intermedi-
ate states are present in both infected and non-infected groups,
while the 62 kDa band is observed only in the infected group at
14 days of infection. The presence of 92 kDa band corresponds to
the precursor state of MMP-9, and is present in both infected and
non-infected groups. It may be also noted a 130 kDa band that is
suggestive of a complex of metalloproteinases, which is seen only
at 14 days after infection. Also, the densitometric analysis of the
bands shows that latent MMP-2 increases from the 5th day of
infection and peaks at 14 days after infection, and its active form
can be observed only at 14 days after infection. On the other hand,
the MMP-9 could be observed only in its precursor form with sig-
niﬁcant expression at 14 days of infection (Fig. 6B).4. Discussion
The thymus is the central lymphoid organ where bone marrow-
derived lymphocyte precursors mature into functional and immu-
nocompetent T-cells. In this context, a functionally competent thy-
mic microenvironment is essential for stromal cells to provide theappropriated signals to T-cell precursors (or thymocytes) that lead
to proliferation, differentiation and generation of diversity [3,23].
There is now accumulating evidence that thymus can be se-
verely affected by many different pathogens and that thymic invo-
lution is frequently found during infectious diseases [5]. Our
laboratory has also reported that the thymus is a target organ dur-
ing Plasmodium berghei infection. Besides the intrathymic presence
of parasites [6], it was observed profound thymic atrophy accom-
panied by severe structural disorganization, characterized by loss
of cortico-medullary delimitation, depletion of double-positive
thymocytes, and alterations in the expression of ECM elements
and chemokines, in such a way that thymocyte migration inside
the thymus is severely compromised [10].
Since MMPs are collectively implicated in the degradation and
remodeling of ECM and vascularization, we decided to investigate
if MMP-2 and MMP-9, as well as their natural tissue inhibitors
TIMP1 and TIMP2, could also play a role in the thymic atrophy ob-
served during Plasmodium berghei infection.
Data presented here show enhanced MMP-2, MMP-9, TIMP-1
and TIMP-2 gene expression in the thymus from Plasmodium berg-
hei-infected animals, at 10 days after infection. At 14 days after
infection, by immunohistochemical technique, we detected the
presence of these proteases in thymic tissue. It is interesting to
note that as the disease progresses the distribution of these mole-
cules is extended to the whole organ. Furthermore, gelatin zymog-
raphy test performed in thymic tissue extracts has demonstrated
Fig. 6. (A): Representative gelatin zymography of MMP-2 and MMP-9 in thymus from non-infected (C) and P. berghei NK65-infected mice (I) after 5, 10 and 14 days of
inoculation. Gelatinase activities at 62, 68, and 72 kDa bands correspond, respectively, to the molecular weights of the active, intermediate, and precursor states of MMP-2,
and gelatinase activity at 92 kDa corresponds to the molecular weight of the precursor MMP-9. (B): Densitometric analysis of (A) shows that precursor MMP-2 increases from
the 5th day of infection and peaks at 14 days after infection, and its active form can be observed only at 14 days after infection. MMP-9 could be observed only in its precursor
form with signiﬁcant expression at 14 days of infection. (⁄p 6 0.05; ⁄⁄⁄p 6 0.0001). The control bar is representative since the data were similar at each time point.
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active forms (68 and 62 kDa). These results are suggestive of MMP-
2 importance in the earlier observed changes in the ECM during
thymic atrophy after plasmodium infection. On the other hand,
the predominance of the band at 92 rather than 82 kDa indicated
that MMP-9 (gelatinase B) is primarily inactive. However, activa-
tion of MMP-9 requires a complex network of mechanisms involv-
ing other matrix metalloproteinases [24,25].The most likely
activator of MMP-9 is thought to be MMP-3 [26] but this protein
was not evaluated in this study. So, more studies are necessary
to investigate the importance of MMP-9 expression changes during
the course of this infection.
Although little data exist on the MMPs and TIMPs activities in
the thymus, the presence of MMPs in different pathophysiology
has already been reported [12,19,27], Kivelä-Rajamäki1 et al. [28]
and Pereira et al. [29] observed an increased expression of MMP-
9 by thymic stromal cells during the development of thymic
lymphoma.
The presence of high levels of TIMPs in the atrophic thymic tis-
sue is intriguing since they are kinetic inhibitors of MMP enzy-
matic activity and thus should contain the extensive tissue
degradation observed. However, literature has shown that in, some
cases, they are involved in the activation of MMPs from their inac-
tive zymogen form to their active form [30,31]. On the other hand,
it has also been related that proinﬂammatory cytokines, such as
Tumor Necrosis Factor-alpha (TNF-a), are able of inhibiting the
activity of TIMPs [32,33]. In fact, previous studies from our group
have shown that TNF-a is increased at 10 days after infection,
and this could explain the presence of TIMPs and their lack of ac-
tion to inhibit MMPs.
A possible limitation of our study could be due to the death of
animals at 15 days after infection. In order to verify MMPs and
TIMPs activities after the parasitemia peak, experiments, usingmice treated with cloroquine, are being conducted now in our lab-
oratory. On the other hand, it is also important to note that litera-
ture shows MMPs as essential molecules for cell migration into the
tissues [34–37]. In this sense, it would be very interesting to inves-
tigate MMPs and TIMPs activities at the beginning of the infection
to examine their possible involvement during intrathymic thymo-
cyte migration.5. Conclusions
The results of this work shown a progressive increase of MMPs
and TIMPs produced in the thymus. At present, the activation of
MMP-2 appeared to be linked to the intense degradation of thymic
extracellular matrix (ECM) observed during plasmodium infection.
We speculate that such alterations can result in loss of thymocytes
by apoptosis and/or in a premature migration of immature T cells
to the periphery, and both of these events could inﬂuence the host
immune response to the infection. It is therefore clear that the pro-
teolytic process occurring in thymic atrophy during plasmodium
infection require further study to clarify the signiﬁcance of MMPs
and TIMPs in both physiological and pathological conditions.Acknowledgments
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